Patents Assigned to Omnio Healer AB
  • Patent number: 10729750
    Abstract: The present invention relates to the use of plasminogen/plasmin and its derivatives as agents for enhancing host defense against infection or other infectious diseases. The invention also relates to a method for screening of compounds which enhance host defense against infection by evaluating the host defense against bacterial arthritis and spontaneous otitis media in an animal model.
    Type: Grant
    Filed: December 9, 2015
    Date of Patent: August 4, 2020
    Assignee: Omnio Healer AB
    Inventors: Tor Ny, Jinan Li, Yongzhi Guo
  • Publication number: 20180360931
    Abstract: The present invention relates to the use of a component of the plasminogen-activating pathway and use of compounds which have the capacity to activate plasminogen directly or via the plasminogen-activating pathway, for prophylaxis, prevention and treatment of periodontal disease including peri-implantitis, healing of periodontal wounds and prompting oral health in human and non-human subjects.
    Type: Application
    Filed: August 28, 2018
    Publication date: December 20, 2018
    Applicant: Omnio Healer AB
    Inventors: Tor NY, Jinan LI, Yongzhi GUO, Tomas LINDH
  • Patent number: 10086052
    Abstract: The present invention relates to the use of a component of the plasminogen-activating pathway and use of compounds which have the capacity to activate plasminogen directly or via the plasminogen-activating pathway, for prophylaxis, prevention and treatment of periodontal disease including peri-implantitis, healing of periodontal wounds and prompting oral health in human and non-human subjects.
    Type: Grant
    Filed: October 23, 2015
    Date of Patent: October 2, 2018
    Assignee: Omnio Healer AB
    Inventors: Tor Ny, Jinan Li, Yongzhi Guo, Tomas Lindh
  • Publication number: 20160243204
    Abstract: The present invention relates to the use of plasminogen/plasmin and its derivatives as agents for enhancing host defense against infection or other infectious diseases. The invention also relates to a method for screening of compounds which enhance host defense against infection by evaluating the host defense against bacterial arthritis and spontaneous otitis media in an animal model.
    Type: Application
    Filed: December 9, 2015
    Publication date: August 25, 2016
    Applicant: Omnio Healer AB
    Inventors: Tor NY, Jinan LI, Yongzhi GUO
  • Publication number: 20160184411
    Abstract: The present invention relates to the use of a component of the plasminogen-activating pathway and use of compounds which have the capacity to activate plasminogen directly or via the plasminogen-activating pathway, for prophylaxis, prevention and treatment of periodontal disease including peri-implantitis, healing of periodontal wounds and prompting oral health in human and non-human subjects.
    Type: Application
    Filed: October 23, 2015
    Publication date: June 30, 2016
    Applicant: Omnio Healer AB
    Inventors: Tor NY, Jinan LI, Yongzhi GUO, Tomas LINDH
  • Patent number: 8679482
    Abstract: The present invention relates to the use of plasminogen and plasmin as agents for enhancing healing of tympanic membrane perforations or other wounds, and for reducing scars or necrotic tissue forming during wound healing. The invention also relates to a method for screening of compounds which enhance wound healing by evaluating the healing of tympanic membrane perforations in an animal model.
    Type: Grant
    Filed: November 30, 2007
    Date of Patent: March 25, 2014
    Assignee: Omnio Healer AB
    Inventors: Tor Ny, Jinan Li, Sten Hellstrom, Per-Olof Eriksson
  • Patent number: 8637010
    Abstract: The present invention relates to the use of plasminogen and plasmin as agents for enhancing healing of tympanic membrane perforations or other wounds, and for reducing scars or necrotic tissue forming during wound healing. The invention also relates to a method for screening of compounds which enhance wound healing by evaluating the healing of tympanic membrane perforations in an animal model.
    Type: Grant
    Filed: October 18, 2005
    Date of Patent: January 28, 2014
    Assignee: Omnio Healer AB
    Inventors: Tor Ny, Jinan Li, Sten Hellstrom, Per-Olof Eriksson
  • Publication number: 20130149321
    Abstract: The present invention relates to the use of plasminogen/plasmin and its derivatives as agents for enhancing host defense against infection or other infectious diseases. The invention also relates to a method for screening of compounds which enhance host defense against infection by evaluating the host defense against bacterial arthritis and spontaneous otitis media in an animal model.
    Type: Application
    Filed: November 26, 2012
    Publication date: June 13, 2013
    Applicant: OMNIO HEALER AB
    Inventor: OMNIO HEALER AB
  • Patent number: 8318661
    Abstract: The present invention relates to the use of plasminogen/plasmin and its derivatives as agents for enhancing host defense against infection or other infectious diseases. The invention also relates to a method for screening of compounds which enhance host defense against infection by evaluating the host defense against bacterial arthritis and spontaneous otitis media in an animal model.
    Type: Grant
    Filed: August 28, 2007
    Date of Patent: November 27, 2012
    Assignee: Omnio Healer AB
    Inventors: Tor Ny, Jinan Li, Yongzhi Guo
  • Publication number: 20110142819
    Abstract: This invention relates to novel methods of promoting the healing or closure of perforated tympanic membranes or wounds, as well as methods for minimizing scar formation and removing necrotic tissue. In particular the invention relates to the use of components of the plasminogen activating system, especially mini-plasminogen, mini-plasmin, micro-plasminogen, micro-plasmin, delta-plasminogen, and delta-plasmintopromote wound healing processes.
    Type: Application
    Filed: January 21, 2009
    Publication date: June 16, 2011
    Applicant: Omnio Healer AB
    Inventors: Tor Ny, Jinan Li, Sten Hellstrom, Per-Olof Eriksson
  • Publication number: 20100099600
    Abstract: The present invention relates to the use of plasminogen/plasmin and its derivatives as agents for enhancing host defense against infection or other infectious diseases. The invention also relates to a method for screening of compounds which enhance host defense against infection by evaluating the host defense against bacterial arthritis and spontaneous otitis media in an animal model.
    Type: Application
    Filed: August 28, 2007
    Publication date: April 22, 2010
    Applicant: OMNIO HEALER AB
    Inventors: Tor Ny, Jinan Li, Yongzhi Guo
  • Publication number: 20100028321
    Abstract: The present invention relates to the use of a component of the plasminogen-activating pathway and use of compounds which have the capacity to activate plasminogen directly or via the plasminogen-activating pathway, for prophylaxis, prevention and treatment of periodontal disease including peri-implantitis, healing of periodontal wounds and prompting oral health in human and non-human subjects.
    Type: Application
    Filed: August 28, 2007
    Publication date: February 4, 2010
    Applicant: OMNIO HEALER AB
    Inventors: Tor Ny, Jinan Li, Yongzhi Guo, Tomas Lindh
  • Publication number: 20080090751
    Abstract: The present invention relates to the use of plasminogen and plasmin as agents for enhancing healing of tympanic membrane perforations or other wounds, and for reducing scars or necrotic tissue forming during wound healing. The invention also relates to a method for screening of compounds which enhance wound healing by evaluating the healing of tympanic membrane perforations in an animal model.
    Type: Application
    Filed: November 30, 2007
    Publication date: April 17, 2008
    Applicant: Omnio Healer AB
    Inventors: Tor Ny, Jinan Li, Sten Hellstrom, Per-Olof Eriksson